Скачать или смотреть Hurdles and challenges in using liquid biopsies in glioblastoma

Stephen Bagley, MD, MSCE, University of Pennsylvania, Philadelphia, PA, describes the limitations of liquid biopsies in detecting glioblastoma. The blood-brain barrier and the localized nature of the disease hinder the detection of tumor-derived cell-free DNA or other tumor-derived materials in the bloodstream. Current liquid biopsy techniques are also not sensitive enough for glioblastoma, which is why they are not typically ordered as routine care for brain cancer patients. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.